Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
151,803,139
Total 13F shares
145,422,829
Share change
-2,761,726
Total reported value
$2,175,120,073
Put/Call ratio
142%
Price per share
$14.96
Number of holders
269
Value change
-$14,779,461
Number of buys
144
Number of sells
107

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q3 2025

As of 30 Sep 2025, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 269 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 145,422,829 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, Amova Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., GEODE CAPITAL MANAGEMENT, LLC, ARK Investment Management LLC, Aristotle Atlantic Partners, LLC, and STATE STREET CORP. This page lists 269 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.